COCH — Envoy Medical Share News
0.000.00%
- $51.24m
- $25.99m
- $0.24m
Brief: Envoy Medical Receives FDA Approval To Advance Its Clinical Trial To Final Stage
Brief: Envoy Medical Enters Satisfaction Agreement With GAT Funding On Aug 25 - SEC Filing
Brief: Envoy Medical Appoints Robert Potashnick As Interim CFO
Brief: Envoy Medical Inc - Secures $10 Million Financing From Glen Taylor
Brief: Envoy Medical Inc - Enters Conversion And Waiver Agreement With Anzu
Brief: Envoy Medical Inc - On Dec 11, Draws $5 Million Under Promissory Note Issued On Aug 27, 2024
Brief: Envoy Medical Receives Another European Patent For Its Modular Cochlear Implant System
Brief: Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study For Breakthrough Hearing Device
U.S. RESEARCH ROUNDUP-Commercial Metals, M&T Bank, Simon Property
Brief: Envoy Medical Secures Lending Facility Of $10M
U.S. RESEARCH ROUNDUP-Carmax, Eli Lilly, Microstrategy
Brief: Envoy Medical Announces Addition Of Medical Device Manufacturing Experience To Its Board Of Directors To Prepare For Scaling
Brief: Envoy Medical Secures Up To $10 Mln Term Debt Financing
India won't aid Canada probe on Sikh separatist's killing till evidence shared - report
Brief: Envoy Medical Says Unaudited Interim Financial Statements For Quarter Ended Sept 30 To Not Be Relied On
Brief: Envoy Medical Provides Third Quarter 2023 Financial Results
Brief: Envoy Medical Announces Publication of Additional Patent for Implantable Cochlear Systems
Brief: Envoy Medical- On Oct 16, Co Through Its Wholly Owned Unit, Entered Into Employment Agreement With Co's Chief Executive Officer, Brent T. Lucas
Brief: New Clinical Publication Reports First Three Patients in Early Feasibility Trial for Envoy Medical’s Fully Implanted Cochlear Device